申请人:Nissan Chemical Industries, Ltd.
公开号:EP1845090A1
公开(公告)日:2007-10-17
The present invention provides compounds usuful for prevention, treatment or allevation of diseases against which activation of the thrombopoietin receptor is effective.
A compound represented by the formula (1):
wherein A, B, R1, L1, R2, L2, L3, Y, L4, R3 and X are the same as defined in the description, a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.
本发明提供的化合物可用于预防、治疗或减轻对血小板生成素受体激活有效的疾病。
由式(1)代表的化合物:
其中A、B、R1、L1、R2、L2、L3、Y、L4、R3和X与说明书中定义的相同,该化合物的同系物、原药或药学上可接受的盐或其溶液。